Luyan Pharma Co.,Ltd.’s Net Profit Rose 2.8% in First Three Quarters of 2023

Luyan Pharma Co.,Ltd. (鹭燕医药股份有限公司) (002788.SZ) reported a net profit of 259.1 million yuan in the first three quarters of 2023, up 2.8% year-on-year.

Meanwhile, the company posted 14.8 billion yuan in revenue, up 3.2% year-on-year.

At the end of the reporting period, it had 11.4 billion yuan in total assets and 8.5 billion yuan in total liabilities, with a liability-to-asset ratio of 74.8%.